General Counsel and commercial business partner accomplished at achieving complex business goals, making deals happen, and obtaining favorable litigation outcomes through strategic thinking, negotiation skills, and the ability to influence others.BUSINESS OBJECTIVESLegal strategy provided 180 days' exclusivity in the market and no legal proceedings, leading to first nine (9) months revenue of $148.3 million from generic Concerta™ and achieved revenues of $147 and $304 million for first two (2) years of Pennsaid™ 2% sales following execution of multi-faceted, follow-on product, legal strategy.DEALSStrategic divestiture of $80 million revenue Optiray™ drug franchise to Japanese company, joint-development and commercialization agreement with Canadian partner (projected sales >$250 million), and led integration efforts associated with $9.3 billion in acquisitions (Cadence, Questcor, and Ikaria).LEGAL EXPERTISELed successful IP litigation achieving favorable monetary settlement in the tens of millions of dollars and gaining market share and set up businesses throughout Eastern Hemisphere to enable successful launch of $2.4 billion, stand-alone, publicly-traded company.Legal Strategy | M&A | Joint-Ventures | Legal Structure Strategy | Securities | Section 16 OfficerCommercial Contracting | Intellectual Property | Regulatory | Compliance | Orange Book | IntegrationNegotiation | Due Diligence | Antitrust | Risk Assessment | USPTO | FDA | DEA | FTC | SECBranded and Generic Products | Promotional Review | Product Labeling | Life Cycle ManagementCountry of Origin | Customs | Licensing | Infringement | Freedom-to-Operate Transfer Agreements | Litigation Management | Corporate Governance | Investor RelationsPharmaceuticals | Medical Devices | Generics | Controlled Substances | Orphan Drugs Biotechnology | Consumer Products | Electrochemistry | Materials | SoftwareEurope | Asia | South America | North America | Australia
Listed skills include Patents, Intellectual Property, Trademarks, Patent Prosecution, and 45 others.